To lead a sustainable energy future, the European Commission and the European Investment Bank have announced an investment of €3.66 billion from the EU’s Modernisation Fund.
James McErlean, GM, Headspace for Work, Europe, discusses how public sector leaders can support productivity levels during the COVID-19 pandemic while being realistic and sensitive to any challenges employees might be experiencing.
Ross Linnett, Founder and CEO of Recite Me, explains how public sector bodies can write a top web accessibility statement to comply with the looming deadline imposed by the UK’s new web accessibility laws.
John Binns, Partner at BCL Solicitors LLP, provides us with fresh insight into COVID-19 and medical cannabis. He ponders if the crisis could bring opportunities for the industry.
The Division of Chemistry at the National Science Foundation, provides an update on their work in driving discovery and development concerning chemistry research that improves the quality of life in the United States.
Sandra Greenbank, Nutritional Therapist & creator of the Corporate Fertility Policy, explores the impact that COVID-19 has had on those struggling with fertility and how employers can offer support.
Skin conditions often get worse when we are stressed – for example, during the COVID-19 pandemic. Have you just been diagnosed with acne rosacea? Are there any tips or tricks on how to manage it? Here, Dr Deborah Lee, Dr Fox Online Pharmacy, explains everything you need to know.
James Badgett, co-founder of Angel Investment Network, explores the further measures that Government should consider to support Britain’s early-stage startups.
Mike Fischer CBE, Founder of the COVID-19 Volunteer Testing Network, details the work being done to keep healthcare workers safe on the frontline and provide regular screening for COVID-19.
Edward Harbison, Corporate Marketing Manager at Instant Offices shares his thoughts on how businesses can be more sustainable after we emerge in a post-COVID world.
Scientists at TCS designed novel chemical compounds using AI that can inhibit the 3CL protease of SARS-CoV-2, which is responsible for viral replication. Ananth Krishnan, Chief Technology Office, TCS, discusses the research here.
